首页> 外国专利> Use of a proteu00ecna L1 of the human papilomavu00ecrus or fragment imunogu00eaico thereto of a first type of HPV vaccination programme to protect against infection and / or HIV disease, method for preventing infection and / or disease with HPV vaccine composition, and kit.

Use of a proteu00ecna L1 of the human papilomavu00ecrus or fragment imunogu00eaico thereto of a first type of HPV vaccination programme to protect against infection and / or HIV disease, method for preventing infection and / or disease with HPV vaccine composition, and kit.

机译:第一类HPV疫苗接种程序的人乳头瘤病毒的蛋白L1或免疫片段的用途,用于预防感染和/或HIV疾病,预防感染和/或HPV疫苗疾病的方法组成和套件。

摘要

Use of a proteu00ecna L1 of the human papilomavu00ecrus or fragment immunogenic the same of a first type of HPV vaccination programme to protect against HPV infection and / or disease, method for preventing infection and / or disease with HPV vaccine composition, and kit.A method for the prevention of HPV infection and / or disease.The method comprising releasing a first vaccine of HPV L1 protein or fragment comprising an immunogenic of the same from at least HPV 16 and HPV 18 and a second HIPV vaccine that does not understand the components of L1 of HIPV 16 and HIPV 18 of the first and the second vaccine. The vaccine comprises an L1 protein or fragment immunogenic thereto of at least one another HPV type ANcogu00eanico, in which the first and second vaccines may be released in any order and the release is separated by an interval of time.
机译:人乳头瘤病毒的蛋白L1或与第一类HPV疫苗接种程序具有免疫原性的片段的用途,用于预防HPV感染和/或疾病,用HPV疫苗组合物预防感染和/或疾病的方法预防HPV感染和/或疾病的方法。该方法包括从至少HPV 16和HPV 18中释放第一株HPV L1蛋白或包含其免疫原性的片段的疫苗和第二株HIPV疫苗不了解第一和第二种疫苗的HIPV 16和HIPV 18的L1成分。疫苗包含至少一种其他HPV型ANcog的L1蛋白或其免疫原性片段,其中第一种和第二种疫苗可以任何顺序释放,释放间隔一定时间。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号